BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 6, 2025
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Xechem Buys Ceptor, Adds Size To Niche Drug Pipeline
Dec. 31, 2003
By
Aaron Lorenzo
Arena Raises $35M Through Sale Of Preferred Convertible Shares
Dec. 30, 2003
By
Aaron Lorenzo
Arena Raises $35M Through Sale Of Preferred Convertible Shares
Dec. 30, 2003
By
Aaron Lorenzo
Inspire Gets Approvable Letter Asking For More Diquafosol Data
Dec. 23, 2003
By
Aaron Lorenzo
Inspire Gets Approvable Letter Asking For More Diquafosol Data
Dec. 23, 2003
By
Aaron Lorenzo
Pharmacopeia Plans To Divide Drug Discovery, Software Units
Dec. 22, 2003
By
Aaron Lorenzo
Pharmacopeia Plans To Divide Drug Discovery, Software Units
Dec. 22, 2003
By
Aaron Lorenzo
Sequenom, P&G Enter $30M Agreement For Osteoporosis
Dec. 19, 2003
By
Aaron Lorenzo
Sequenom, P&G Enter $30M Agreement For Osteoporosis
Dec. 19, 2003
By
Aaron Lorenzo
FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche
Dec. 17, 2003
By
Aaron Lorenzo
Previous
1
2
…
160
161
162
163
164
165
166
167
168
…
237
238
Next